We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Tianlong and KHB Group Showcase Integrated Molecular and Immunoassay Systems

By LabMedica International staff writers
Posted on 17 Nov 2025

Tianlong, together with parent company KHB Group, is presenting its latest systems at MEDICA 2025. More...

The exhibit highlights clinical diagnostics built around the Panall 8000 All‑In‑One Molecular Diagnosis System and the Gentier mini Real‑Time Polymerase Chain Reaction (PCR) System.

Tianlong Panall 800 is an all-in-one molecular diagnosis platform designed for simplicity, security, and full workflow integration. It integrates sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis within a single system. By enabling a true sample-in, result-out process with one-key operation, the Panall 8000 provides significant convenience and efficiency for laboratory professionals.

The Gentier Mini Real Time PCR System is designed for mobile settings, small laboratories, and on-site testing. Its excellent performance and portability address the challenges of limited workspace and fragmented samples in laboratories, making PCR experiments easier, more accurate, and more efficient. The system is suitable for a wide range of applications, including animal disease and infectious disease monitoring, food safety, scientific research, and more.

For immunoassay automation, KHB is highlighting the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer. This compact, fully automated desktop analyzer from the KHB Polaris series is designed for small and medium-sized laboratories, while also supporting emergency testing needs in large hospitals and third-party laboratories.

Related Links:
Tianlong
KHB


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Connectivity Solution
EKF Link
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.